During the early months of the COVID-19 pandemic, Pepticom identified the opportunity to apply its artificial intelligence (AI) platform to rapidly generate high-quality peptide molecules that ...

BEIJING, Jan. 8, 2025 /PRNewswire/ -- In a recent achievement, DP Technology's hit discovery platform RiDYMO® has successfully designed a cyclic peptide targeting β-catenin, a historically ...

Cyclic peptides are an emerging and promising area of drug research. The new study, led by U-M College of Pharmacy researchers Lisa Mydy and Roland Kersten, revealed a mechanism by which plants ...

cyclic peptides and various peptide-drug conjugates, it said in a Jan. 9 press release. Financial and square footage details of the project weren’t disclosed. BioDuro’s new facility features a ...

Fig. 3 Experimental Results of 29 Cyclic Peptide Molecules Dr. Dongdong Wang, Co-President of DP Technology's Drug Discovery Unit, emphasized the platform's ability to tackle undruggable targets and ...

The RiDYMO® platform's success with β-catenin demonstrates its potential to accelerate the development of orally available cyclic peptide drugs, potentially transforming the pharmaceutical ...